Stephan Neumann

Prof. Dr. Stephan Neumann

Small Animal Clinic, Institute of Veterinary Medicine, Faculty of Agricultural Sciences, Georg-August University Goettingen, 37077 Goettingen, Germany
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

20 March 2021 in Animals
Verified
Journal Article
Open access
PDF file
Nancy De BriyneNancy De Briyne
Nancy De Briyne
DHDanny Holmes
Danny Holmes
ISIan Sandler
Ian Sandler
ESEnid Stiles
Enid Stiles
DSDharati Szymanski
Dharati Szymanski
AAArturo Anadón
Arturo Anadón
As cannabis-derived products have become more available, veterinarians are seeing more cases of toxicosis. In addition, animal owners are having an increasing interest in using these products for their pets. This review looks at the situation in Europe and North America, the different types of cannabis and cannabis-derived products with historical examples of use in animals, and the cannabis industry. The existing regulatory framework for use in humans and animals as medicines and/or supplements was examined. Finally, a review of the clinical indications for which medicinal cannabis is authorised, a discussion of toxicosis, and recommendations and warnings around medical cannabis use are presented.

1 August 2016 in Journal of Dairy Science
Verified
Journal Article
Closed access
SFStephani Fischer
Stephani Fischer
RBRolf Bauerfeind
Rolf Bauerfeind
CCClaus-Peter Czerny
Claus-Peter Czerny
Stephan NeumannStephan Neumann
Stephan Neumann
Neonatal calf diarrhea is still one of the most important diseases in calf rearing, and severe diarrhea has a marked effect on animal welfare. Furthermore, significant economic losses can result from this disease due to high mortality rates, high medical costs, and low weight gain. To avoid a fatal outcome of the disease, it is crucial that vulnerable calves are identified as early as possible. Interleukin-6 is described as an early and reliable prognostic marker in several diseases. In this study, 20 scouring calves were tested by ELISA for their IL-6 serum concentrations. Samples were collected twice, at the beginning of diarrhea and 7 to 10d later. Regarding the clinical outcome after 7 to 10d, calves were classified as recovered or nonrecovered. A receiver operating characteristic analysis was conducted to determine the prognostic value of IL-6 for the progress of clinical symptoms. At the beginning of diarrhea, the IL-6 concentration was significantly higher in nonrecovering calves compared with those that recover 7 to 10d after the onset of diarrhea. Interleukin-6 proved to be a useful additional parameter in the clinical examination. High initial IL-6 values can support the decision for closer monitoring and an adapted therapeutic strategy for the respective calves. This may help to prevent unnecessary animal suffering and reduce economic losses.

1 September 2003 in Comparative Clinical Pathology
Verified
Journal Article
Closed access
PDF file
Stephan NeumannStephan Neumann
Stephan Neumann

1 June 2005 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
PDF file
Stephan NeumannStephan Neumann
Stephan Neumann
FKFranz‐Josef Kaup
Franz‐Josef Kaup

24 March 2023 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
Stephan NeumannStephan Neumann
Stephan Neumann
SSStephan Siegert
Stephan Siegert
AFAnneke Fischer
Anneke Fischer
Introduction: Defensins are peptides with antimicrobial and immunomodulatory effects. Their concentration could be altered during infections and thus provide information on the prognosis and course of the disease. The aim of the present study was to investigate the defensin concentration in cows with mastitis in order to find correlations between clinical expression and course of the disease and the defensin concentration in milk and blood.Methods: A total of 85 dairy cows were examined. Of these, 30 animals suffered from acute clinical mastitis, 25 animals were diagnosed with subclinical mastitis and 30 animals were considered a healthy comparison group. Beta-Defensin-4 (DEFB-4) was determined by a species-specific enzyme-linked immunosorbent assay (ELISA) (Bovine Defensin Beta 4 ELISA Kit, MyBioSource).Results: The highest concentrations of DEFB-4 were detected in the animals with acute clinical mastitis. Values of 0 to 895 pg/mL (median: 115 pg/mL) were measured in milk and 40–1,016 pg/mL (median: 245 pg/mL) in serum. The concentrations of this group differed significantly from those of the animals with subclinical mastitis (p < 0.0001 serum; p = 0.015 milk). In this group, concentrations of 15–211 pg/mL (median: 46 pg/mL) were recorded in milk and 20-271 pg/mL (median: 85 pg/mL) in serum.Discussion: Our results also show that in cases of acute mastitis after 12 days of treatment there is still an active inflammatory process in the tissue, because no significant reduction of somatic cells and defensin could be found after re-examination. Since the DEFB-4 concentrations of animals with clinical mastitis that had to be treated with antibiotics differed significantly from those of animals with subclinical mastitis that did not require antibiotic treatment, it can be assumed that bovine DEFB-4 is an important endogenous parameter for the defense against bacterial infections of the udder.